Target intelligence / Profile preview

DNA damage induced by beta radiation from iodine-131 decay

Molecular classification
DNA, Genomic material, Other (process/biological outcome; not a distinct molecular entity)
01

Overview

DNA damage via beta radiation from iodine-131 decay is a biological outcome occurring when cells are exposed to beta particles released during the radioactive decay of I-131. Beta particles penetrate tissues and cause DNA damage primarily by generating reactive oxygen species (ROS), leading to single- and double-strand breaks, base modifications, and lesions within DNA. These DNA lesions trigger cellular repair pathways, cell cycle arrest, and often apoptosis. This mechanism is exploited in cancer therapy (notably for thyroid cancers) but carries risks of genotoxicity, secondary cancer, and normal-tissue toxicity. Biomarkers like γ-H2AX and micronuclei frequency are used to assess this damage. Importantly, this term describes a physical process and its biological effects, not a discrete molecular target[2][1][3][4][5][6][8].

Other names
Beta-radiation induced DNA damageDNA lesions from beta particlesGenomic damage by beta radiation
02

Mechanism of action

Indirectly: Generation of reactive oxygen species (ROS) leading to DNA single-strand breaks (SSBs), double-strand breaks (DSBs), base and sugar modifications; Directly: Beta particles can physically ionize DNA bonds, causing SSBs and DSBs.

03

Biological functions

Genome integrityCell cycle regulation (including cell cycle arrest)ApoptosisDNA repair (including base excision repair [BER], non-homologous end-joining [NHEJ])Induction of mutations and genomic instability
04

Disease associations

Cancer (therapeutically exploited; also a risk for secondary malignancy)Genomic instabilityRadiation toxicity
05

Safety considerations

Normal tissue toxicity (especially bone marrow, gastrointestinal, etc.)Secondary cancer development (e.g. leukemia)Off-target genomic instability and mutagenesisDose-dependent toxicity, repair pathway inadequacy
06

Interacting drugs

Beta-emitting radiopharmaceuticals (e.g., Iodine-131, Strontium-89)
07

Biomarkers

γ-H2AX foci (marker of DSBs)53BP1 foci (DSB sensor protein accumulation)PARP activity (repair of SSBs)Bcl-2/Bax ratio (apoptosis signaling)Fas/FasL expression (extrinsic apoptotic pathway)Micronucleus assay (genotoxicity assessment)

Beyond the preview

Go deeper on DNA damage induced by beta radiation from iodine-131 decay.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA damage induced by beta radiation from iodine-131 decay.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call